Mission
ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| Advisory Board |
|
Stuart Altman, PhD Ellen Andrews, PhD Carmella Bocchino, RN, MBA Kathleen Buto, MPA Donald E. Casey Jr., MD, MPH, MBA, FACP Patrick Courneya, MD Robert Donnelly G. Scott Gazelle, MD, PhD, MPH George Isham, MD, MS Carolyn Langer, MD, JD, MPH David Lansky, PhD Keith D. Lillemoe, MD Robert McDonough, MD, JD, MPP Newell McElwee, PharmD, MSPH Dolores Mitchell Joshua Ofman, MD, MSHS Rita Redberg, MD, MSc, FACC Murray Ross, PhD Lewis Sandy, MD Michael Sherman, MD, MBA, MS Eric Silfen, MD, MSHA Andrea Sutcliffe, BA (Hons) Brian Sweet, BS Pharm, MBA Bill Thorwarth, MD Reed Tuckson, MD Gail Wilensky, PhD |
Ongoing Appraisals
Recent News Releases
- New Members of the New England Comparative Effectiveness Public Advisory Council (CEPAC) Named for 2013
- Next Public Meeting of CEPAC to Address Community Health Worker Programs
- New Report and Action Guide on Obstructive Sleep Apnea from New England CEPAC Will Help Patients, Clinicians, and Insurers Improve Care for Adults